← Back to Search
Differential Expression Of Peroxiredoxins In Prostate Cancer: Consistent Upregulation Of PRDX3 And PRDX4
Anamika Basu, H. Banerjee, H. Rojas, Shannalee R. Martinez, Sourav Roy, Z. Jia, M. Lilly, M. De León, C. Casiano
Published 2011 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The peroxiredoxins (PRDXs) are emerging as regulators of antioxidant defense, apoptosis, and therapy resistance in cancer. Because their significance in prostate cancer (PCa) is unclear, we investigated their expression and clinical associations in PCa.
This paper references
E. Röther (1995)
Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival.
W. Sakr (2000)
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
R. Hoffman (2001)
Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma
V. Kinnula (2002)
Nonredundant Antioxidant Defense by Multiple Two-Cysteine Peroxiredoxins in Human Prostate Cancer Cells
C. Shen (2002)
Peroxiredoxins in breast carcinoma.
P. Karihtala (2003)
Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria*
T. Chang (2004)
Peroxiredoxins, a novel protein family in lung cancer
Siri Lehtonen (2004)
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
G. Smyth (2004)
Peroxiredoxins, oxidative stress, and cell proliferation.
S. Immenschuh (2005)
Antinuclear autoantibodies in prostate cancer: Immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis
T. Daniels (2005)
Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
X. Ouyang (2005)
cancer : Immunity to LEDGF / p 75 , a survival protein highly expressed in prostate tumors and cleaved during apoptosis
D Wittschieber (2005)
Abate-Shen C. Loss-offunction of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis
X Ouyang (2005)
Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
J. Park (2005)
Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.
C. Quan (2006)
The role of stress proteins in prostate cancer.
A. So (2007)
Peroxiredoxin‐4 interacts with and regulates the thromboxane A2 receptor
P. Giguère (2007)
Earlier age at diagnosis: another dimension in cancer disparity?
S. Karami (2007)
Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis
J. Lin (2007)
Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation.
S. Park (2007)
Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor.
Chang Xia (2007)
Inflammation in prostate carcinogenesis
A. D. Marzo (2007)
Increased expression of mitochondrial glycerophosphate dehydrogenase and antioxidant enzymes in prostate cancer cell lines/cancer
Subir K. Roy Chowdhury (2007)
Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+
S. Simoni (2008)
Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high‐mobility group protein B1
M. Shiota (2008)
Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
B. Kumar (2008)
Explaining the Race Difference in Prostate Cancer Stage at Diagnosis
B. Jones (2008)
Tumor immunobiological differences in prostate cancer between African-American and European-American men.
Tiffany A. Wallace (2008)
Peroxiredoxins, a novel target in cancer radiotherapy.
B. Zhang (2009)
Prx1 Enhances Androgen Receptor Function in Prostate Cancer Cells by Increasing Receptor Affinity to Dihydrotestosterone
R. Chhipa (2009)
Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis.
Kiyoon Kim (2009)
Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.
C. Pritchard (2009)
Evidence for field cancerization of the prostate
L. Nonn (2009)
Oxidative stress in prostate cancer.
Lakshmipathi Khandrika (2009)
TNF‐related apoptosis‐inducing ligand suppresses PRDX4 expression
H. Wang (2009)
Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma
M. Cha (2009)
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75
Melanie Mediavilla-Varela (2009)
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Juxiang Cao (2009)
Cancer Statistics, 2009
A. Jemal (2009)
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by the stress oncoprotein LEDGF/ p75
M Mediavilla-Varela (2009)
Cancer Statistics, 2009
L. Tanoue (2010)
Nuclear Grading Versus Gleason Grading in Small Samples Containing Prostate Cancer: A Tissue Microarray Study
D. Wittschieber (2010)
Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis.
Marjo Pylväs (2010)
Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
S. Kalla Singh (2010)
This paper is referenced by
MicroRNA-383 promotes reactive oxygen species-induced autophagy via downregulating peroxiredoxin 3 in human glioma U87 cells
Zhou Xu (2021)
The Cytotoxic Effect of Copper (II) Complexes with Halogenated 1,3-Disubstituted Arylthioureas on Cancer and Bacterial Cells
A. Chrzanowska (2021)
Peroxiredoxin 6 translocates to the plasma membrane of human sperm under oxidative stress during cryopreservation.
Ling Xin (2021)
PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer In Vitro and In Vivo
Y. Chen (2020)
Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis
Jianbo Zheng (2020)
Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.
Jianbo Zheng (2020)
Therapeutic effect of hydrogen peroxide via altered expression of glutathione S-transferase and peroxiredoxin-2 in hepatocellular carcinoma.
Zehra Hashim (2020)
Suppression of PRDX4 inhibits cell proliferation and invasion of ectopic endometrial stromal cells in endometriosis
Yong Luo (2020)
Proteomics analysis of Formalin Fixed Paraffin Embedded tissues in the investigation of prostate cancer.
A. Mantsiou (2020)
PRDX4 and Its Roles in Various Cancers
W. Jia (2019)
Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis1
K. Tiedemann (2018)
Peroxiredoxins in Cancer and Response to Radiation Therapies
T. Forshaw (2019)
Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential
Zhenkun Liu (2019)
PRDX3 is associated with metastasis and poor survival in uveal melanoma
P. Ramasamy (2019)
The Role of Peroxiredoxin Family in Cancer Signaling
Yosup Kim (2019)
Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma
T. Falcon (2018)
Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis
Sunny Trivedi (2018)
Liver proteome response of pre-harvest Atlantic salmon following exposure to elevated temperature
Waldo G. Nuez-Ortín (2018)
Role of ncRNAs in Hepatocellular Carcinoma
J. Zhao (2018)
The Role of Glucocorticoid Signaling in Prostate Cancer Health Disparities
Leanne W. Burnham (2018)
Peroxiredoxin 1 (PRDX1) Suppresses Progressions and Metastasis of Osteosarcoma and Fibrosarcoma of Bone
Yongxiang Wang (2018)
The prognostic values of the peroxiredoxins family in ovarian cancer
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer.
M. Hampton (2017)
Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation.
Min-Yao Jiang (2017)
Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer
Z. Lv (2017)
Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes
Jaroslaw Szczyrba (2017)
New Challenges to Study Heterogeneity in Cancer Redox Metabolism
R. Benfeitas (2017)
Peroxiredoxin 1 – an antioxidant enzyme in cancer
Chenbo Ding (2016)
Proteomic and phenotypic approaches to assess nutritional physiology in Atlantic salmon
Wg Nuez-Ortin (2017)
Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients
S. Khan (2017)
The role of peroxiredoxins in cancer
A. Nicolussi (2017)
The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre‐clinical models
Leanne Woods-Burnham (2017)See more